US 9399662
Concurrent chemotherapy and immunotherapy
granted A61KA61K2039/55522A61K2039/6081
Quick answer
US patent 9399662 (Concurrent chemotherapy and immunotherapy) held by The Board of Regents of the University of Texas System expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/55522, A61K2039/6081, A61K39/00, A61K39/0005